本页面由Tiger Trade Technology Pte. Ltd.提供服务

Karyopharm Therapeutics Inc.

7.63
-0.1000-1.29%
盘后7.700.0700+0.92%19:47 EDT
成交量:149.62万
成交额:1,222.56万
市值:1.40亿
市盈率:-0.43
高:9.04
开:7.76
低:7.44
收:7.73
52周最高:10.99
52周最低:3.51
股本:1,831.03万
流通股本:1,600.05万
量比:2.31
换手率:9.35%
股息:- -
股息率:- -
每股收益(TTM):-17.9300
每股收益(LYR):-17.9300
净资产收益率:-891.05%
总资产收益率:-41.56%
市净率:-0.48
市盈率(LYR):-0.43

数据加载中...

公司资料

公司名字:
Karyopharm Therapeutics Inc.
交易所:
NASDAQ
成立时间:
2008
员工人数:
228
公司地址:
85 Wells Avenue,2nd Floor, Suite 210,Newton,Massachusetts,United States
邮编:
02459-3298
电话:
传真:
- -
简介:
Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司,专注于发现和开发针对核转运靶点的新型一线药物,用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。

董事

名称
职位
Richard Paulson
Chief Executive Officer and Director and President
Barry E. Greene
Director
Chen Schor
Director
Christy J. Oliger
Director
Deepa R. Pakianathan
Director
Garen G. Bohlin
Director
Zhen Su
Director

股东

名称
职位
Richard Paulson
Chief Executive Officer and Director and President
Lori Macomber
Chief Financial Officer and Executive Vice President and Treasurer
Michael Mano
Chief Legal Officer and Executive Vice President and Secretary
Reshma Rangwala
Chief Medical Officer and Executive Vice President
Sohanya Cheng
Chief Commercial Officer and Executive Vice President
Stuart Poulton
Chief Development Officer and Executive Vice President